Dataset Information


Lysosome-targeted octadecyl-rhodamine B-liposomes enhance lysosomal accumulation of glucocerebrosidase in Gaucher's cells in vitro.

ABSTRACT: We hypothesized that liposomes modified with lysosomotropic octadecyl-rhodamine B (Rh) and loaded with therapeutic glucocerebroside velaglucerase alfa (VPRIV™) will improve lysosomal delivery of the enzyme into Gaucher's cells.Confocal microscopy and flow cytometry were used to evaluate the ability of Rh-modified liposomes loaded with VPRIV to improve the lysosomal targeting in monocyte-derived macrophages and Gaucher's fibroblasts.Confocal microscopy demonstrated that Rh-modified liposomes localized primarily in the lysosomes. As confirmed by flow cytometry using specific substrate 5-(pentafluorobenzoylamino)fluorescein diglucoside, intralysosomal accumulation of VPRIV in the cells treated with Rh-modified liposomes was significantly increased (up to 68%) relative to the cells treated with plain liposomes or free VPRIV.Rh-modified lysosomotropic liposomes can improve lysosomal accumulation of liposomal enzymes both in nonphagocytic Gaucher's fibroblasts and phagocytic monocyte-derived macrophages.

SUBMITTER: Thekkedath R 

PROVIDER: S-EPMC3644353 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3335981 | BioStudies
2015-01-01 | S-EPMC4552301 | BioStudies
2019-01-01 | S-EPMC6826018 | BioStudies
1000-01-01 | S-EPMC6294013 | BioStudies
2014-01-01 | S-EPMC4136546 | BioStudies
1000-01-01 | S-EPMC5785733 | BioStudies
2013-01-01 | S-EPMC4208290 | BioStudies
2019-01-01 | S-EPMC6314264 | BioStudies
2008-01-01 | S-EPMC2276591 | BioStudies
2016-01-01 | S-EPMC6274290 | BioStudies